| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |